Effect of cerivastatin on peripheral capillary permeability to albumin and peripheral nerve function in diabetic rats

Diabetes and Metabolism

Volumn 33, Issue 3, 2007, Pages 189-196

  Cohen Boulakia, F E ^a,b   Tarhzaoui, K ^a   Valensi, P E ^a   Lestrade, R A ^a,b   Albertini, J P ^a   Behar, A ^a,b  

^a UNIVERSITÉ PARIS 13   (France)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

Capillary filtration of albumin; Diabetes; Lymphatic dysfunction; Nerve function; Statins

Indexed keywords

ALBUMIN; CERIVASTATIN; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ROSUVASTATIN; TRIACYLGLYCEROL; LIPID; PYRIDINE DERIVATIVE; SERUM ALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL PERMEABILITY; BODY WEIGHT; CAPILLARY; CAPILLARY PERMEABILITY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; EDEMA; ELECTROMYOGRAPHY; LYMPHATIC SYSTEM DISEASE; MALE; MICROCIRCULATION; MOTOR NERVE; MUSCLE WEAKNESS; NERVE CONDUCTION; NERVE FUNCTION; NONHUMAN; PERIPHERAL NEUROPATHY; RAT; SENSORY NERVE; STREPTOZOCIN DIABETES; TRIACYLGLYCEROL BLOOD LEVEL; AGING; ANIMAL; BLOOD; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; FILTRATION; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SENSORY NERVE CELL; WISTAR RAT;

AGING; ANIMALS; CAPILLARIES; CAPILLARY PERMEABILITY; CHOLESTEROL; DIABETES MELLITUS, EXPERIMENTAL; FILTRATION; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIPIDS; MALE; NEURONS, AFFERENT; PYRIDINES; RATS; RATS, WISTAR; SERUM ALBUMIN;

EID: 34249910091     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabet.2006.11.012     Document Type: Article

References (35)

1. Nitenberg A., Paycha F., Ledoux S., Attali J.R., and Valensi P. Coronary artery responses to physiological stimuli are improved by deferoxamine but not by l-arginine in noninsulin dependent diabetic patients with angiographically normal coronary arteries and no other risk factors. Circulation 97 (1998) 736-743
2. Valensi P., Smagghue O., Pariès J., Lormeau B., Bostnavarron M., and Attali J.R. Acetylcholine-induced skin vasodilatation is altered in non diabetic and diabetic overweight patients. In 20th Eur. Conf. on Microcirculation (1998), Monduzzi Editore 55-58
3. Valensi P., and Behar A. Clinical implications of impaired microcirculation. Int. Angiol. 14 suppl 1 (1995) 26-31
4. Valensi P., Cohen-Boulakia F., Attali J.R., and Behar A. Changes in capillary permeability in diabetic patients. Clin Hemorrheol 17 (1997) 389-394
5. Valensi P., Behar A., De Champvallins M., Attalah M., Cohen-Boulakia F., and Attali J.R. Effect of a purified micronised flavonoid fraction on the capillary filtration of albumin in diabetic patients. Diabet. Med. 13 (1996) 882-888
6. Williamson J.R., Chang K., Tilton R.G., Prater C., Jeffrey J.R., Weigel J.R., et al. Increased vascular permeability in spontaneously diabetic BB/W rats and in rats with mild versus severe streptozotocin-induced diabetes. Prevention by aldose reductase inhibitors. Diabetes 36 (1987) 813-821
7. Parving H.H., Rossing N., and Jansen H.A. Increased metabolic turnover rate and transcapillary escape rate of albumin in essential hypertension. Circ. Res. 35 (1974) 544-552
8. Valensi P., Behar A., Attalah M., Cohen-Boulakia F., Pariès J., and Attali J.R. Increased capillary filtration of albumin in diabetic patients. Relation with gender, hypertension, macroangiopathy and neuropathy. Metabolism 47 (1998) 503-507
9. Nukada H., Pollock M., and Allpress S. Experimental cold injury to peripheral nerve. Brain 104 (1981) 779-811
10. John S., Schneider M.P., Delles C., Jacobi J., and Schmieder R.E. Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients. Am. Heart J. 149 (2005) 473
11. Wang T.D., Chen W.J., Lin J.W., Cheng C.C., Chen M.F., and Lee Y.T. Efficacy of fenofibrate and simvastatin on endothelial function and inflammatory markers in patients with combined hyperlipidemia: relations with baseline lipid profiles. Arteriosclerosis 170 (2003) 315-323
12. Koh K.K. Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability. Cardiovasc. Res. 47 (2000) 648-657
13. Miyahara S., Kiryu J., Yamashiro K., Miyamoto K., Hirose F., and Tamura H. Simvastatin inhibits leukocyte accumulation and vascular parmeability in the retinas of rats with streptozotocin-induced diabetes. Am. J. Pathol. 164 (2004) 1697-1706
14. Mooradian A.D., Haas M.J., Batejko O., Hovsepyan M., and Feman S.S. Statins ameliorate endothelial barrier permeability changes in the cerebral tissue of STZ induced diabetic rats. Diabetes 54 (2005) 2977-2982
15. Cameron N., Cotter M., Inkster M., and Nangle M. Looking to the future: diabetic neuropathy and effects of rosuvastatin on neurovascular function in diabetes models. Diabetes Res. Clin. Pract. 61 (2003) 35-39
16. Tarhzaoui K., Behar A., Lestrade R.A., Hort-Legrand C., Cohen-Boulakia F.E., and Valensi P.E. Nerve electrophysiological changes in rats with early induced diabetes. J. Diabetes Complic. (2006) [submitted for publication]
17. Thomas P.K., Fraher J.P., O'Leary D., Moran M.A., Cole M., and King R.H.M. Relative growth and maturation of axon size and myelin thickness in the tibial nerve of the rat. Effect of STZ-induced diabetes. Acta Neuropathol. (Berl.) 79 (1990) 375-386
18. Zemp C., Bestetti G., and Rossi G.L. Morphological and morphometric study of peripheral nerves from rats with streptozotocin-induced diabetes mellitus. Acta Neuropathol. (Berl.) 53 (1981) 99-106
19. Cohen-Boulakia F., Valensi P.E., Boulahdour H., Lestrade R., Dufour-Lamartinie J.F., Hort-Legrand C., et al. In vivo sequential study of skeletal muscle capillary permeability in diabetic rats. Effect of anthocyanosides. Metabolism 49 (2000) 880-885
20. Cohen-Boulakia F., Behar A., Valensi P., and Othmani S. Study of capillary filtration and lymphatic resorption by double labelling albumin and red blood cells in cyclic edema and diabetes. Eur J Lymphol 4 (1993) 75-78
21. Bischoff H., and Heller A.H. Preclinical and clinical pharmacology of cerivastatin. Am. J. Cardiol. 27 (1998) 18J-25J
22. Ota T., Takamura T., Ando H., Nohara E., Yamashita H., and Kobayashi K. Preventive effect of cerivastatin on diabetic nephropathy through suppression of glomerular macrophage recruitment in a rat model. Diabetologia 46 (2003) 843-851
23. Susic D., Varagic Y., Ahn J., Slama M., and Frohlich E.D. Beneficial pleiotropic vascular effects of rosuvastatin in two hypertensive models. J. Am. Coll. Cardiol. 42 (2003) 1091-1097
24. Sicard P., Lauzier B., Oudot A., Busseuil D., Collin B., Duvillard D., et al. A treatment with rosuvastatin induced a reduction of arterial pressure and a decrease of oxidative stress in spontaneously hypertensive rats. Arch Mal Coeur 98 (2005) 804-808
25. Pruefer D., Scalia R., and Lefer A.M. Simvastatin inhibits leukocyte-endothelial cell interactions and protects against inflammatory processes in normocholesterolemic rats. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 2894-2900
26. Diomede L., Albani D., Sottocorno M., Donati M.B., Bianchi M., Fruscella P., et al. In vivo anti-inflammatory effect of statins is mediated by nonsterol mevalonate products. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 1327-1339
27. Buchtal F., and Rosenfalk A. Evoked action potentials and conduction velocity in human sensory nerves. Brain Res. 3 (1966) 1-122
28. Baba M., Nukada H., Mcmorran D., Takahashi K., Wada R., and Yagihashi S. Prolonged ischemic conduction failure after reperfusion in diabetic nerve. Muscle Nerve 33 (2006) 350-355
29. Nukada H., Lynch C.D., and Mcmorran P.D. Aggravated reperfusion injury in STZ-diabetic nerve. J Periph Nerve Syst 7 (2002) 37-43
30. Von Keutz E., and Schluter G. Preclinical safety evaluation of cerivastatin, a novel HMG-CoA reductase inhibitor. Am. J. Cardiol. 82 4B (1998) 115-175
31. Schaefer W.H., Lawrence J.W., Loughlin A.F., Stoffregen D.A., Mixson L.A., Dean D.C., et al. Evaluation of ubiquinone concentration and mitochondrial function relative to cerivastatin-induced skeletal myopathy in rats. Toxicol. Appl. Pharmacol. 194 (2004) 10-23
32. Seachrist J.L., Loi C.M., Evans M.G., Criswell K.A., and Rotwell C.E. Roles of exercise and pharmacokinetics in cerivastatin-induced skeletal muscle toxicity. Toxicol. Sci. 88 (2005) 551-561
33. Jeppesen U., Gaist D., Smith T., and Sindrup S.H. Statins and peripheral neuropathy. Eur. J. Clin. Pharmacol. 54 (1999) 835-838
34. Gazerin S., Abd-El-Hady H., Gheith O., Rasem M., Saad M., El-Sayed K., et al. Neuromuscular toxicity in nephrotic patients treated with fluvastatin. J. Nephrol. 15 (2002) 690-695
35. Gaist D., Jeppesen U., Andersen M., Garcia Rodriguez L., Hallas J., and Sindrup S. Statins and risk of polyneuropathy a case control study. Neurology 58 (2002) 1333-1337